The Dana Foundation

Dana Foundation: Using Brain and Immune Imaging Innovations to Improve Human Health

Program Summary

The Dana Foundation’s neuroimaging research program focuses on improving human brain and brain-immune functioning to promote health, and prevent and treat disease. Funds support pilot-testing by investigators who are early in their research careers of promising, high-risk, and innovative ideas with a direct clinical application. Successful studies are then anticipated to be competitive for larger-scale support from other funders.

The Foundation invites each institution to submit one preliminary application, using either or both:


Each U.S. medical school dean, and the presidents of the few selected biomedical research institutions that have been invited by letter, may nominate one applicant. The applicant may use either physiological/structural or cellular imaging or both. To be considered under this Program, the application must be countersigned by the medical school dean or invited biomedical institute’s president.

Investigations must be applicable to human brain or brain-immune functioning or malfunctioning to be considered for funding. Submitted proposals should focus on imaging in patients or patient tissues, and healthy volunteers. Applications for animal model studies of brain conditions or injuries will be considered only if they relate directly to humans but cannot yet feasibly be undertaken in humans, and are anticipated to be translated into human research following the three-year grant period.

Award Information

Funding of up to $200,000 payable over three years is provided for proposed studies utilizing structural/physiological or cellular/molecular imaging proposals by promising early career investigators who have not yet been awarded more than one independent research grant (R01 from the NIH or equivalent from another Federal agency).

The Foundation does not provide support for indirect costs. However, up to 10 percent of the total grant award may be used to purchase equipment for the study.  The balance is to be used to meet direct research costs. Research that can be supported through clinical income should not be submitted. Studies should be designed to obtain meaningful data within the grant award period of up to three years.

Internal Selection Procedure

The Office of the Vice President for Research and the Carver College of Medicine have established an internal review procedure to select the UI nominee.  Applications will be reviewed according to the sponsor's selection criteria. Consideration will also be given to UI institutional strengths and strategic directions. Potential applicants must submit, using the preselection link below, the following information: 
  1. A two page C V
  2. A description of the proposed research. It should have the following elements:
  1. Please be sure the project is identified on each page and number the pages.
The above materials must be submitted no later than 5:00 p.m. on Thursday, January 31, 2013. The selected nominee will be asked to complete the full application package in accordance with the sponsor's deadline of noon, Thursday, February 21, 2013.

Proposal Due to OVPRED01/31/2013 Not open for submission deadline passed
Date Due to DSP or UIF02/14/2013
Date Due to Sponsor02/21/2013
Required LOI Due DateN/A
Non-Required LOI Due DateN/A
Sponsor URL:

Admin/Reviewer Login here first

Back to the WINS main page